| RS2082900460 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2082910890 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2082914528 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS2082914686 |
TLK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2082915385 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082923260 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082929857 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2082934908 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2082940446 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2082945195 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2082968071 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS2082970808 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2082973177 |
MLH1
|
Health Risk |
Pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS2082976497 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2082978607 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2082985381 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2082990862 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS2082994980 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2082999197 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2083028943 |
FCHO1
|
Health Risk |
Pathogenic |
Immunodeficiency 76, Immunodeficiency 76 |
| RS2083030924 |
SPG11
|
Health Risk |
Pathogenic |
— |
| RS2083036101 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2083036870 |
LOC130056973;SPG11
|
Health Risk |
Pathogenic |
— |
| RS2083039160 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2083042256 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2083042425 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2083042603 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 28 |
| RS2083046669 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2083048367 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2083056830 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, DEPDC5-related disorder |
| RS2083058016 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2083116648 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2083140726 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2083146343 |
SLC9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lichtenstein-Knorr syndrome, Lichtenstein-Knorr syndrome |
| RS2083161364 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2083161760 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2083174891 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2083175858 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2083178407 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2083180883 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2083214834 |
SLC9A1
|
Health Risk |
Pathogenic |
Lichtenstein-Knorr syndrome, Lichtenstein-Knorr syndrome |
| RS2083230922 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2083233502 |
SHANK3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2083233723 |
SHANK3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2083254756 |
NDUFB10
|
Health Risk |
Pathogenic |
Mitochondrial complex 1 deficiency, nuclear type 35 |
| RS2083259164 |
FZR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Global developmental delay |
| RS2083271355 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083275468 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083275928 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Autism spectrum disorder |
| RS2083278122 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2083278313 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083278717 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083279575 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083280147 |
SHANK3
|
Health Risk |
Likely pathogenic |
Schizophrenia 15, Phelan-McDermid syndrome |
| RS2083280269 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2083281950 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083283892 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2083287837 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2083287955 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2083292400 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2083293616 |
SHANK3
|
Health Risk |
Pathogenic |
Intellectual disability, Phelan-McDermid syndrome |
| RS2083297043 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS2083299114 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083311058 |
SPG11
|
Health Risk |
Pathogenic |
SPG11-related spastic paraplegia, SPG11-related spastic paraplegia |
| RS2083315314 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2083325659 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2083326327 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2083331705 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2083336878 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2083337165 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2083338520 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2083358123 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2083359401 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS2083360139 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2083361357 |
SHANK3
|
Health Risk |
Pathogenic/Likely pathogenic |
SHANK3-related disorder, SHANK3-related disorder |
| RS2083361660 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS2083362624 |
SHANK3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2083377690 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2083381117 |
IFNAR1
|
Health Risk |
Pathogenic |
— |
| RS2083394185 |
GPR143
|
Health Risk |
Likely pathogenic |
Ocular albinism, type I |
| RS2083402714 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2083403132 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2083404326 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2083405700 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2083411159 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2083412120 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2083414866 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2083416349 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2083425688 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Colorectal cancer |
| RS2083435502 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2083438278 |
GPR143
|
Health Risk |
Pathogenic |
Ocular albinism, type I |
| RS2083438857 |
TTN
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 9, Hypertrophic cardiomyopathy 9 |
| RS2083440966 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, ATM-related cancer predisposition |
| RS2083441908 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2083443709 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2083444037 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2083444895 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2083448445 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2083453557 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2083454135 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |